Duloxetine
Product Images NDC 60760-951

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 60760-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

951-60 (Duloxetine 951 60)

951-60 (Duloxetine 951 60)
FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)
FDA Label Image

Figure-2 (Duloxetine Fig2)

Figure-2 (Duloxetine Fig2)
FDA Label Image

Figure-3 (Duloxetine Fig3)

Figure-3 (Duloxetine Fig3)
FDA Label Image

Figure 4: Percentage Of Dpnp Adult Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (study Dpnp-2) (Duloxetine Fig4)

Figure 4: Percentage Of Dpnp Adult Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (study Dpnp-2) (Duloxetine Fig4)
This text appears to be a chart or table showing the percentage of patients improved in relation to different treatments. It mentions the medications "Duloxetine 60 mg BID" and "Duloxetine 60 mg QD" as well as a placebo. The chart also shows different levels of pain improvement from baseline, ranging from 10% to 100%. Overall, it seems to be evaluating the effectiveness of different treatments in improving patients' pain levels.*
FDA Label Image

Figure 5 (Duloxetine Fig5)

Figure 5 (Duloxetine Fig5)
FDA Label Image

Figure 6 (Duloxetine Fig6)

Figure 6 (Duloxetine Fig6)
This text appears to be a description of a clinical study evaluating the effectiveness of different doses of Duloxetine in reducing pain. The study compares three different doses of Duloxetine (120 mg, 60 mg, and 20 mg) taken once daily to a placebo. The text also mentions the percentage of patients who experienced improvement in pain and provides a graphical representation of the percent improvement in pain from baseline. The graph shows that as the dose of Duloxetine increases, the percentage improvement in pain also increases.*
FDA Label Image

Figure 7 (Duloxetine Fig7)

Figure 7 (Duloxetine Fig7)
Percentage of Patients Improved: This text appears to show a chart or graph displaying the percentage of patients who experienced improvement in their condition. The data is represented using numbers, with the range of improvement shown as 0 to 100. It seems that there are two different treatment groups being compared - a placebo group and a group taking a medication called Duloxetine at different dosages (60/120 mg once). The chart does not provide specific details about the type of condition being treated or the time frame over which the improvement was measured.*
FDA Label Image

Figure 8 (Duloxetine Fig8)

Figure 8 (Duloxetine Fig8)
FDA Label Image

Figure 10: Percentage Of Adult Patients With Oa Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (study Oa-1) (Duloxetine Fig9)

Figure 10: Percentage Of Adult Patients With Oa Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (study Oa-1) (Duloxetine Fig9)
FDA Label Image

Chemical Structure (Duloxetine Str)

Chemical Structure (Duloxetine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.